TruAlt Bioenergy · NSE: TRUALT · BSE: 544545
Q4 FY26 results · Jan–Mar 2026
TruAlt Bioenergy reported revenue from operations of ₹595.52 crore and net profit of ₹60.95 crore for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 595.52 | — | — | 713.24 | −16.5% |
| Other income | 31.39 | — | — | 17.62 | +78.1% |
| Total income | 626.91 | — | — | 730.86 | −14.2% |
| Profit before tax | 83.70 | — | — | 89.68 | −6.7% |
| Net profit for the period | 60.95 | — | — | 69.19 | −11.9% |
| Attributable to shareholders of the company | 59.88 | — | — | 69.33 | −13.6% |
| EPS, basic (₹) | 6.99 | — | — | 8.07 | −13.4% |
| Net margin (%) | 10.2 | — | 9.7 |
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 603.22 | — | — | 703.02 | −14.2% |
| Other income | 13.40 | — | — | 17.70 | −24.3% |
| Total income | 616.62 | — | — | 720.72 | −14.4% |
| Profit before tax | 79.00 | — | — | 85.82 | −7.9% |
| Net profit for the period | 56.73 | — | — | 66.02 | −14.1% |
| EPS, basic (₹) | 6.62 | — | — | 7.70 | −14.0% |
| Net margin (%) | 9.4 | — | 9.4 |
Consolidated
- Filed with BSE
- 25 Sep 2026, 12:02 IST
- Board meeting
- 22 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 25 Sep 2026, 12:02 IST
- Board meeting
- 22 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE